Wintest
6721
Showcase
3909
Beauty Kadan Holdings
3041
Cybozu
4776
KODAMA CHEMICAL INDUSTRY
4222
(Q2)Mar 31, 2024 | (Q1)Dec 31, 2023 | (FY)Sep 30, 2023 | (Q4)Sep 30, 2023 | (Q3)Jun 30, 2023 | (Q2)Mar 31, 2023 | (Q1)Dec 31, 2022 | (FY)Sep 30, 2022 | (Q4)Sep 30, 2022 | (Q3)Jun 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | 2.52%115.44M | -8.08%114.38M | -16.96%475.43M | -7.96%123.79M | -14.12%114.6M | -25.06%112.6M | -19.39%124.43M | -14.03%572.56M | -15.10%134.5M | -16.85%133.44M |
Cost of revenue | -25.73%53.59M | -25.66%51.18M | -4.21%291.01M | -2.44%73.49M | -1.65%76.53M | -4.93%72.15M | -7.93%68.85M | 10.43%303.8M | 1.31%75.33M | 8.38%77.81M |
Gross profit | 52.93%61.86M | 13.69%63.19M | -31.38%184.42M | -14.97%50.31M | -31.56%38.08M | -45.61%40.45M | -30.16%55.58M | -31.25%268.75M | -29.62%59.17M | -37.27%55.63M |
Operating expense | -14.89%57.36M | -6.17%63.92M | 1.49%263.34M | -10.64%59.75M | 9.64%68.09M | 6.62%67.39M | 1.20%68.12M | -1.33%259.48M | 2.98%66.86M | -5.59%62.1M |
Operating profit | 116.70%4.5M | 94.23%-723K | -951.24%-78.93M | -22.66%-9.44M | -364.08%-30.01M | -341.62%-26.95M | -202.08%-12.54M | -92.75%9.27M | -140.18%-7.69M | -128.23%-6.47M |
Net non-operating interest income (expenses) | -97.80%2K | 0 | 13,800.00%139K | 0.00%1K | 0 | 91K | 47K | 0.00%1K | 0.00%1K | 0 |
Non-operating interest income | -97.80%2K | --0 | 13,800.00%139K | 0.00%1K | --0 | --91K | --47K | 0.00%1K | 0.00%1K | --0 |
Net investment income | ||||||||||
Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
Income from associates and other participating interests | ||||||||||
Special income (charges) | -397.41M | -387.41M | 0 | 0 | 0 | 0 | ||||
Less:Other special charges | ---- | ---- | --10M | --0 | --0 | ---- | ---- | ---- | ---- | ---- |
Less:Write off | ---- | ---- | --387.41M | ---- | ---- | ---- | ---- | --0 | ---- | ---- |
Other non-operating income (expenses) | 168K | |||||||||
Income before tax | 112.22%4.5M | 94.21%-723K | -5,233.53%-476.03M | -5,057.05%-396.68M | -364.08%-30.01M | -430.44%-36.85M | -201.69%-12.49M | -92.70%9.27M | -140.82%-7.69M | -128.23%-6.47M |
Income tax | 0.00%238K | 0.00%237K | -36.12%2.83M | 264.77%2.12M | 111.01%237K | -93.53%238K | -94.35%237K | -88.97%4.43M | -120.13%-1.29M | -130.12%-2.15M |
Net income | 111.50%4.26M | 92.46%-960K | -9,993.86%-478.86M | -6,125.38%-398.8M | -601.21%-30.25M | -596.13%-37.09M | -257.40%-12.72M | -94.43%4.84M | -151.42%-6.41M | -127.37%-4.31M |
Net income continuous operations | 111.50%4.26M | 92.45%-960K | -9,991.82%-478.86M | -6,125.40%-398.8M | -601.18%-30.25M | -596.15%-37.09M | -257.37%-12.72M | -94.43%4.84M | -151.42%-6.41M | -127.37%-4.31M |
Noncontrolling interests | ||||||||||
Net income attributable to the company | 111.50%4.26M | 92.46%-960K | -9,993.86%-478.86M | -6,125.38%-398.8M | -601.21%-30.25M | -596.13%-37.09M | -257.40%-12.72M | -94.43%4.84M | -151.42%-6.41M | -127.37%-4.31M |
Preferred stock dividends | ||||||||||
Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Net income attributable to common stockholders | 111.50%4.26M | 92.46%-960K | -9,993.86%-478.86M | -6,125.38%-398.8M | -601.21%-30.25M | -596.13%-37.09M | -257.40%-12.72M | -94.43%4.84M | -151.42%-6.41M | -127.37%-4.31M |
Gross dividend payment | ||||||||||
Basic earnings per share | 111.46%1.51 | 92.48%-0.34 | -9,934.10%-170.13 | -6,060.43%-141.69 | -584.08%-10.74 | -589.96%-13.18 | -255.33%-4.52 | -94.49%1.73 | -151.22%-2.3 | -127.69%-1.57 |
Diluted earnings per share | 111.46%1.51 | 92.48%-0.34 | -10,226.79%-170.13 | -6,060.43%-141.69 | -584.52%-10.747 | -604.98%-13.18 | -262.01%-4.52 | -94.29%1.68 | -153.86%-2.3 | -129.24%-1.57 |
Dividend per share | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |